Alpa Laboratories Limited

NSEI:ALPA Stock Report

Market Cap: ₹2.8b

Alpa Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Alpa Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Alpa Laboratories Limited (NSE:ALPA) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 03
Alpa Laboratories Limited (NSE:ALPA) Looks Inexpensive But Perhaps Not Attractive Enough

Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Sep 22
Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

Sep 06
Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Aug 26
Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Jun 17
Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24
Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05
Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31
Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28
With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alpa Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:ALPA - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202497320839101N/A
6/30/20241,087162N/AN/AN/A
3/31/20241,087168-2736N/A
12/31/20231,148178N/AN/AN/A
9/30/20231,148185354373N/A
6/30/20231,054130N/AN/AN/A
3/31/20239301267889N/A
12/31/20221,00745N/AN/AN/A
9/30/20221,01248-42-34N/A
6/30/20221,139103N/AN/AN/A
3/31/20221,1231417799N/A
12/31/20211,121156N/AN/AN/A
9/30/20211,159139-78-37N/A
6/30/20211,128105N/AN/AN/A
3/31/202197672-49-17N/A
12/31/202090769N/AN/AN/A
9/30/202081758N/AN/AN/A
6/30/202082139N/AN/AN/A
3/31/202086019152178N/A
12/31/20198699N/AN/AN/A
9/30/20198886N/AN/AN/A
6/30/201981711N/AN/AN/A
3/31/201978010-19-10N/A
3/31/201862828N/A-127N/A
3/31/201763525N/A170N/A
3/31/201653668N/A-219N/A
3/31/2015574-14N/A-18N/A
12/31/2014618-19N/AN/AN/A
9/30/2014627-46N/AN/AN/A
6/30/2014573-60N/AN/AN/A
3/31/2014567-52N/A81N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ALPA's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if ALPA's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if ALPA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ALPA's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if ALPA's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ALPA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 21:47
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alpa Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research